Literature DB >> 23105590

Choronic effects of Lamotrigine on liver function in adult male rats.

M H Meshkibaf1, A Ebrahimi, R Ghodsi, A Ahmadi.   

Abstract

A number of newly developed antiepileptic drugs are currently in use, among them Lamotrigine (LTG) is more common. Despite the extensive use of this drug, it has not been possible to predict the side effects especially the hepatotoxic reactions after long-term treatment. The present study was designed to find out alterations in the activities of liver enzymes after chronic exposure of rats to different dose of LTG. Adults male (Wistar) rats were treated orally with LTG [5 mg/kg body weight or 25 mg/kg body wt.] for 60 days. After the experimental period, auto analyzer carried out liver function tests. The liver histopathology was obtained after scarifying the rats. There was a significant increase in the level of ALP, AST, ALT and bilirubin at therapeutic dose of LTG. The increase level of these enzymes and bilirubin at toxic dose were much higher and significant. However, the total protein and albumin significantly decreased at toxic dose of LTG. Elevation of liver enzymes and bilirubin after chronic exposure of rats to high dose of LTG reflects hepatocellular damage that may lead to hepatitis. It is concluded that regular liver function and drug monitoring should follow the treatment with LTG.

Entities:  

Keywords:  Antiepileptic; Hepatitis; Lamotrigine; and Liver function

Year:  2006        PMID: 23105590      PMCID: PMC3453760          DOI: 10.1007/BF02913087

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  10 in total

1.  [Therapeutic benefits of monotherapy with lamotrigine].

Authors:  A Oliveros-Juste; V Bertol; A Oliveros-Cid; B Sánchez-Marín; R Alarcia
Journal:  Rev Neurol       Date:  1999 Dec 16-31       Impact factor: 0.870

Review 2.  Potential hepatotoxicity of lamotrigine.

Authors:  M Fayad; R Choueiri; M Mikati
Journal:  Pediatr Neurol       Date:  2000-01       Impact factor: 3.372

3.  Lamotrigine distribution in two postmortem cases.

Authors:  B Levine; R A Jufer; J E Smialek
Journal:  J Anal Toxicol       Date:  2000-10       Impact factor: 3.367

Review 4.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

Review 5.  Antiepileptic drugs in development: prospects for the near future.

Authors:  I E Leppik
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

Review 6.  Lamotrigine--a novel approach.

Authors:  B S Meldrum
Journal:  Seizure       Date:  1994-12       Impact factor: 3.184

Review 7.  Fatal progressive hepatic necrosis associated with lamotrigine treatment: a case report and literature review.

Authors:  Kerith Overstreet; Christopher Costanza; Cynthia Behling; Tarrek Hassanin; Eliezer Masliah
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

8.  Hepatic injury associated with diphenylhydantoin therapy. A clinicopathologic study of 20 cases.

Authors:  F G Mullick; K G Ishak
Journal:  Am J Clin Pathol       Date:  1980-10       Impact factor: 2.493

9.  Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

Authors:  M J Leach; C M Marden; A A Miller
Journal:  Epilepsia       Date:  1986 Sep-Oct       Impact factor: 5.864

10.  Human safety of lamotrigine.

Authors:  T Betts; G Goodwin; R M Withers; A W Yuen
Journal:  Epilepsia       Date:  1991       Impact factor: 5.864

  10 in total
  2 in total

1.  Chemoprotective role of triphala against 1,2-dimethylhydrazine dihydrochloride induced carcinogenic damage to mouse liver.

Authors:  Aditi Sharma; Krishan Kumar Sharma
Journal:  Indian J Clin Biochem       Date:  2011-05-15

2.  Effect of ethanolic leaf extract of Trianthema portulacastrum L. On aflatoxin induced hepatic damage in rats.

Authors:  G Sharmila Banu; G Kumar; A G Murugesan
Journal:  Indian J Clin Biochem       Date:  2009-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.